ATYR - aTyr Pharma, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$5.13
DETAILS
HIGH:
$17.00
LOW:
$1.00
MEDIAN:
$1.25
CONSENSUS:
$5.13
UPSIDE:
946.94%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 0.2 | 0.2 | 0.4 | 10.4 | 0 | 10.5 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.6 | 0 | 0 | 1.7 | 1.3 | 17.3 | 14.0 | 0.7 | 0.7 | 0.9 | 0 | 0 | 0 | 0.5 |
| Gross Profit | (1.4) | 0.2 | 0.4 | 8.7 | (1.3) | (6.8) | (13.6) | (0.7) | (0.7) | (0.9) | 0 | 0 | 0 | (0.5) |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 60.2 | 54.4 | 42.3 | 42.8 | 23.3 | 17.3 | 14.0 | 20.4 | 30.1 | 44.2 | 34.5 | 16.8 | 13.8 | 7.7 |
| SG&A Expenses | 17.6 | 13.8 | 13.0 | 12.3 | 10.8 | 9.1 | 9.4 | 11.7 | 16.4 | 14.2 | 13.1 | 6.8 | 5.7 | 4.3 |
| Other Expenses | (1.6) | 0 | 0 | 0 | (1.3) | (17.3) | (14.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 76.3 | 68.1 | 55.3 | 55.1 | 32.7 | 9.1 | 9.4 | 32.1 | 46.4 | 58.4 | 47.6 | 23.6 | 19.5 | 12.1 |
| Operating Income | ||||||||||||||
| Operating Income | (77.6) | (67.9) | (54.9) | (46.4) | (34.0) | (15.9) | (23.0) | (32.8) | (47.1) | (59.3) | (47.6) | (23.6) | (19.5) | (12.6) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 | 0.4 | 0.3 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||
| EBITDA | (76.1) | (66.4) | (52.2) | (44.7) | (32.5) | (14.6) | (22.3) | (32.1) | (46.4) | (57.0) | (45.3) | (22.7) | (18.8) | (12.0) |
| EBIT | (77.6) | (67.9) | (54.9) | (46.4) | (33.8) | (15.9) | (23.0) | (34.5) | (47.1) | (57.9) | (46.2) | (23.6) | (19.5) | (12.6) |
| Income Before Tax | (74.1) | (64.0) | (50.4) | (45.3) | (33.8) | (16.2) | (23.8) | (34.5) | (48.2) | (57.9) | (48.0) | (24.4) | (20.0) | (12.9) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 | 0 | 0 | 0 |
| Net Income | (74.1) | (64.0) | (50.4) | (45.3) | (33.8) | (16.2) | (23.6) | (34.5) | (48.2) | (57.9) | (48.0) | (24.4) | (20.0) | (17.6) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -0.80 | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | -16.13 | -26.16 | -34.20 | -42.42 | -422.73 | -429.90 | -0.45 |
| EPS (Diluted) | -0.80 | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | -16.13 | -26.16 | -34.20 | -42.42 | -415.63 | -397.39 | -0.45 |
| Shares Outstanding | 93.0 | 74.3 | 53.6 | 28.4 | 19.1 | 9.2 | 3.4 | 2.1 | 1.8 | 1.7 | 1.1 | 0.1 | 0.1 | 39.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 10.7 | 11.1 | 22.5 | 10.0 | 2.3 | 17.0 | 9.2 | 23.0 | 21.1 | 38.4 |
| Short-Term Investments | 67.9 | 61.1 | 75.6 | 56.2 | 105.6 | 14.7 | 21.9 | 26.6 | 64.0 | 33.8 |
| Net Receivables | 0.9 | 1.7 | 2.4 | 11.8 | 0.4 | 2.0 | 0.1 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 80.2 | 82.0 | 103.0 | 80.9 | 113.6 | 35.5 | 31.9 | 50.8 | 87.0 | 74.8 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 10.4 | 11.9 | 14.0 | 11.6 | 1.8 | 3.0 | 4.1 | 1.9 | 2.3 | 1.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 2.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.0 |
| Other Non-Current Assets | 1.3 | 3.0 | 3.6 | 3.4 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 |
| Total Non-Current Assets | 13.9 | 14.9 | 17.7 | 14.9 | 2.0 | 3.2 | 4.3 | 1.9 | 2.4 | 5.8 |
| Total Assets | 94.2 | 96.8 | 120.7 | 95.8 | 115.5 | 38.7 | 36.2 | 52.7 | 89.4 | 80.5 |
| Current Liabilities | ||||||||||
| Account Payables | 3.9 | 4.3 | 3.5 | 3.1 | 1.0 | 1.4 | 0.8 | 1.0 | 2.3 | 2.6 |
| Short-Term Debt | 1.5 | 0 | 0 | 0 | 0 | 0 | 8.7 | 7.8 | 5.0 | 0.3 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 |
| Other Current Liabilities | 9.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Total Current Liabilities | 15.1 | 15.0 | 16.4 | 13.9 | 6.0 | 5.9 | 12.9 | 10.8 | 10.4 | 8.5 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.3 | 14.7 | 9.2 |
| Deferred Tax Liabilities | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 11.7 | 12.0 | 13.8 | 10.6 | 0.4 | 1.4 | 2.2 | 8.3 | 14.7 | 9.2 |
| Total Liabilities | 26.9 | 27.0 | 30.2 | 24.5 | 6.4 | 7.2 | 15.2 | 19.1 | 25.1 | 17.7 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (606.2) | (532.0) | (468.0) | (417.6) | (372.3) | (338.5) | (322.3) | (298.7) | (264.2) | (216.0) |
| Accumulated Other Comprehensive Income | (0.0) | (0.0) | (0.1) | (0.4) | (0.3) | (0.0) | (0.0) | (0.1) | (0.1) | (0.1) |
| Total Stockholders' Equity | 67.5 | 70.0 | 90.7 | 71.5 | 109.3 | 31.6 | 21.2 | 33.6 | 64.2 | 62.8 |
| Total Liabilities & Equity | 94.2 | 96.8 | 120.7 | 95.8 | 115.5 | 38.7 | 36.2 | 52.7 | 89.4 | 80.5 |
| Debt Metrics | ||||||||||
| Total Debt | 12.0 | 13.3 | 15.1 | 11.5 | 1.4 | 2.2 | 11.7 | 16.0 | 19.7 | 9.5 |
| Net Debt | 1.3 | 2.2 | (7.4) | 1.6 | (1.0) | (14.7) | 2.5 | (6.9) | (1.4) | (28.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (74.1) | (64.0) | (50.4) | (45.3) | (33.8) | (16.2) | (23.8) | (34.5) | (48.2) | (57.9) |
| Depreciation & Amortization | 1.6 | 1.5 | 2.7 | 1.7 | 1.3 | 1.3 | 1.4 | 0.7 | 0.7 | 0.9 |
| Stock-Based Compensation | 5.0 | 3.0 | 2.6 | 2.2 | 1.6 | 1.5 | 1.8 | 0 | 0 | 0 |
| Change in Working Capital | 7.5 | (6.9) | 15.0 | (0.8) | (2.6) | (2.3) | 0.2 | (1.4) | (1.7) | (1.4) |
| Other Non-Cash Items | (1.9) | (2.7) | (3.2) | 0.4 | 0.4 | 0.5 | 0.4 | 7.7 | 10.8 | 7.2 |
| Operating Cash Flow | (62.0) | (69.1) | (33.2) | (41.9) | (33.1) | (15.3) | (20.0) | (31.1) | (42.4) | (52.9) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.1) | (0.1) | (4.2) | (1.6) | (0.2) | (0.2) | (0.1) | (0.6) | (1.3) | (0.6) |
| Acquisitions | 0.0 | 0.0 | 0 | 0 | 0.1 | 0.0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (93.4) | (69.1) | (107.0) | (42.1) | (126.5) | (21.1) | (40.6) | (40.3) | (77.7) | (28.1) |
| Sales/Maturities of Investments | 86.6 | 86.4 | 91.0 | 90.8 | 35.1 | 28.1 | 45.6 | 78.1 | 51.3 | 62.2 |
| Other Investing Activities | 1.9 | 0 | 0.0 | 0.2 | 0 | 0 | 0.1 | 0 | 0 | 0 |
| Investing Cash Flow | (5.1) | 17.2 | (20.1) | 47.2 | (91.6) | 6.9 | 4.9 | 37.2 | (27.6) | 33.5 |
| Financing Activities | ||||||||||
| Net Debt Issuance | (0.5) | (0.5) | (0.4) | (0.1) | 0 | (9.1) | (8) | (4.7) | 9.9 | 4.5 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.4 | 0.2 |
| Financing Cash Flow | 66.0 | 39.9 | 66.2 | 5.5 | 110.0 | 16.1 | 1.3 | (4.2) | 52.7 | 4.7 |
| Cash Position | ||||||||||
| Net Change in Cash | (1.0) | (12.0) | 12.9 | 10.8 | (14.6) | 7.7 | (13.8) | 1.9 | (17.3) | (14.6) |
| Cash at Beginning | 14.0 | 26.0 | 13.1 | 2.3 | 17.0 | 9.2 | 23.0 | 21.1 | 38.4 | 53.0 |
| Cash at End | 13.0 | 14.0 | 26.0 | 13.1 | 2.3 | 17.0 | 9.2 | 23.0 | 21.1 | 38.4 |
| Free Cash Flow | (62.1) | (69.2) | (37.4) | (43.5) | (33.3) | (15.5) | (20.1) | (31.7) | (43.7) | (53.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 0.2 | 0.2 | 0.4 | 10.4 | 0 | 10.5 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (1.4) | 0.2 | 0.4 | 8.7 | (1.3) | (6.8) | (13.6) | (0.7) | (0.7) | (0.9) | 0 | 0 | 0 | (0.5) |
| Operating Income | (77.6) | (67.9) | (54.9) | (46.4) | (34.0) | (15.9) | (23.0) | (32.8) | (47.1) | (59.3) | (47.6) | (23.6) | (19.5) | (12.6) |
| Net Income | (74.1) | (64.0) | (50.4) | (45.3) | (33.8) | (16.2) | (23.6) | (34.5) | (48.2) | (57.9) | (48.0) | (24.4) | (20.0) | (17.6) |
| EPS (Diluted) | -0.80 | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | -16.13 | -26.16 | -34.20 | -42.42 | -415.63 | -397.39 | -0.45 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 10.7 | 11.1 | 22.5 | 10.0 | 2.3 | 17.0 | 9.2 | 23.0 | 21.1 | 38.4 | ||||
| Total Assets | 94.2 | 96.8 | 120.7 | 95.8 | 115.5 | 38.7 | 36.2 | 52.7 | 89.4 | 80.5 | ||||
| Total Debt | 12.0 | 13.3 | 15.1 | 11.5 | 1.4 | 2.2 | 11.7 | 16.0 | 19.7 | 9.5 | ||||
| Stockholders' Equity | 67.5 | 70.0 | 90.7 | 71.5 | 109.3 | 31.6 | 21.2 | 33.6 | 64.2 | 62.8 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (62.0) | (69.1) | (33.2) | (41.9) | (33.1) | (15.3) | (20.0) | (31.1) | (42.4) | (52.9) | ||||
| Capital Expenditure | (0.1) | (0.1) | (4.2) | (1.6) | (0.2) | (0.2) | (0.1) | (0.6) | (1.3) | (0.6) | ||||
| Free Cash Flow | (62.1) | (69.2) | (37.4) | (43.5) | (33.3) | (15.5) | (20.1) | (31.7) | (43.7) | (53.5) | ||||